The broader markets turned lower with marginal loss. The market breadth also turned negative as about 1366 shares declined against 1293 advancing shares on the BSE.
Healthcare company Themis Medicare shares touched a record high of Rs 650, up 16 percent intraday on pact with US company for injectable products. “Themis and Nevakar LLC has signed an agreement to develop injectable products that will be further developed, manufactured and commercialised by Nevakar in the US & select global markets,” the pharma company said in its filing.
The New Jersey-based pharmaceutical firm Nevakar has expertise in commercialising pharma products in the US as well as global markets for many years.
Oil prices fell on worries that US rig counts would continue to rise and that returning Libyan and Nigerian exports would stoke a global supply glut. Brent crude futures were trading at USD 45.97 per barrel, down 1.33 percent, from their last settlement. US West Texas Intermediate futures were down 1.18 percent, at USD 43.39 a barrel.
Equity benchmarks erased more than half of gains in afternoon trade on weak Europe cues and profit booking in banks stocks.
The 30-share BSE Sensex was up 147.41 points at 28560.30 and the 50-share NSE Nifty gained 25.40 points at 8767.95 whereas the broader markets turned lower with marginal loss.